Cancer remains the second leading cause of death in the United States, yet for many patients, access to the specialists they need depends on where they live. Today, just under half (45%) of U.S. counties have a practicing oncologist. For patients in underserved communities, timely cancer care often requires long travel times or comes with delays that can affect outcomes.
The challenge intensifies when blood disorders are involved. One of the most frequent issues, anemia, affects roughly 30–90% of patients. Other blood-related complications, such as neutropenia or thrombocytopenia (from therapy), also occur frequently. And hematologic malignancies comprise their own subset of cancer diagnoses. To add to the issue, hematologists remain one of the most limited specialties in healthcare. Only a small percentage of physicians who complete hematology fellowships go on to practice hematology full-time, leaving many hospitals without consistent access to this expertise.
Without new care models, these coverage gaps will continue to widen, and patients will bear the brunt of the impact.
The Role of Hematology in Cancer Care
Hematology focuses on diseases of the blood and bone marrow. From anemia and clotting conditions to leukemia and other blood cancers, these specialists are in high demand. In oncology care, that expertise is essential. Hematologists help shape treatment plans, manage complications caused by chemotherapy and radiation, and address blood-related issues that can determine whether a patient can safely continue therapy.
Despite their importance, hematologists are typically found only in large academic medical centers. This means that community hospitals often lack the coverage needed to support patients with complex cancer-related blood disorders. These gaps in care are difficult to close through traditional staffing approaches.
How Telemedicine Extends Specialty Care
Telemedicine presents a new avenue for expanding access to oncology and hematology. The secure virtual platforms and close coordination with on-site clinical teams enable these remote specialists to support patient care in real time, when and where needed.
Within a telemedicine model, oncologists and hematologists work alongside bedside nurses and physicians to evaluate patients, guide treatment decisions, monitor complications, and adjust care plans as conditions evolve. This added support and access can help hospitals reduce avoidable transfers, support timely interventions, and maintain continuity of care for patients who might otherwise need to leave their community for treatment.
Why Specialists Choose Telemedicine
Telemedicine is also reshaping the practice of hematology and oncology. Many physicians face growing caseloads, burnout, and limited flexibility in traditional care models. Virtual care enables specialists to focus on clinical decision-making while collaborating across multiple hospitals and care teams, improving the overall sustainability of the practice.
A Hybrid Model for the Future
Telemedicine does not replace in-person cancer care. Instead, it strengthens it. In a hybrid model, community hospitals continue to deliver treatment on site while bringing in virtual subspecialty support when cases become more complex or when an additional perspective is needed.
For patients, that often means staying close to home while still benefiting from specialist input throughout diagnosis, treatment decisions, and follow-up care. For hospitals, it can extend clinical reach while supporting on-the-ground care teams.
Adding Tele-Oncology or Tele-Hematology to Your Hospital
Access to oncology and hematology care is becoming one of the most pressing challenges facing healthcare systems. Limited specialist availability, combined with rising patient demand, has left many hospitals searching for sustainable ways to close care gaps without compromising quality.
Telemedicine assists hospitals by introducing oncology and hematology expertise into the care process without patient transfers. Through hybrid models, specialists support local teams at key decision points, helping guide treatment and manage complications when timing and experience are most consequential. With the help of telemedicine, your patients can receive consistent, informed care with fewer delays or transfers.
If you are interested in learning more about Eagle Telemedicine’s Tele-Oncology or Tele-Hematology, give us a call. We look forward to learning how we can best support your organization’s step into cancer care with hybrid healthcare.
Related Posts:
What It Takes To Turn Telemedicine Into a Core Part of Care Delivery
Transitions in Modern Healthcare: The Benefit of a Fractional FTE with Telemedicine
